The Effect of Modified Porcine Surfactant Alone or in Combination with Polymyxin B on Lung Homeostasis in LPS-Challenged and Mechanically Ventilated Adult Rats
暂无分享,去创建一个
A. Calkovska | M. Grendár | H. Skovierová | D. Mokra | I. Zila | J. Kopincova | P. Mikolka | M. Kolomaznik | P. Kosutova | K. Matasova | Z. Nova | J. Topercerova | I. Žila | J. Kopincová
[1] A. Calkovska,et al. Short-Term versus Long-Term Culture of A549 Cells for Evaluating the Effects of Lipopolysaccharide on Oxidative Stress, Surfactant Proteins and Cathelicidin LL-37 , 2020, International journal of molecular sciences.
[2] R. Veldhuizen,et al. New insights into exogenous surfactant as a carrier of pulmonary therapeutics. , 2019, Biochemical pharmacology.
[3] J. Johansson,et al. Natural Derived Surfactant Preparation As a Carrier of Polymyxin E for Treatment of Pseudomonas aeruginosa Pneumonia in a Near-Term Rabbit Model. , 2019, Journal of aerosol medicine and pulmonary drug delivery.
[4] A. Calkovska,et al. Alveolar-Capillary Membrane-Related Pulmonary Cells as a Target in Endotoxin-Induced Acute Lung Injury , 2019, International journal of molecular sciences.
[5] S. Meng,et al. Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials , 2019, BMC Pulmonary Medicine.
[6] J. Li,et al. Intracellular localization of polymyxins in human alveolar epithelial cells , 2018, The Journal of antimicrobial chemotherapy.
[7] A. Calkovska,et al. The Perturbation of Pulmonary Surfactant by Bacterial Lipopolysaccharide and Its Reversal by Polymyxin B: Function and Structure , 2018, International journal of molecular sciences.
[8] Wei Zhang,et al. GLP-1 Analogue Liraglutide Enhances SP-A Expression in LPS-Induced Acute Lung Injury through the TTF-1 Signaling Pathway , 2018, Mediators of inflammation.
[9] A. Calkovska,et al. Pulmonary surfactant and bacterial lipopolysaccharide: the interaction and its functional consequences. , 2017, Physiological research.
[10] Fanfan Zhou,et al. Potential Toxicity of Polymyxins in Human Lung Epithelial Cells , 2017, Antimicrobial Agents and Chemotherapy.
[11] Jinle Lin,et al. Apoptosis and surfactant protein-C expression inhibition induced by lipopolysaccharide in AEC II cell may associate with NF-κB pathway. , 2017, The Journal of toxicological sciences.
[12] E. Pessoa,et al. Polymyxin B Nephrotoxicity: From Organ to Cell Damage , 2016, PloS one.
[13] M. Valvano,et al. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. , 2016, FEMS microbiology reviews.
[14] X-J Zhang,et al. The localization of SP-B and influences of lipopolysaccharide on it. , 2016, European review for medical and pharmacological sciences.
[15] M. Balaan,et al. Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.
[16] Fanfan Zhou,et al. Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins. , 2015, The Journal of antimicrobial chemotherapy.
[17] R. Mallampalli,et al. The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections. , 2015, Annals of the American Thoracic Society.
[18] T. Hoffmann,et al. DPP4 Inhibitors increase differentially the expression of surfactant proteins in Fischer 344 rats , 2014, Acta physiologica.
[19] M. Kemp,et al. Polymyxin B Agonist Capture Therapy for Intrauterine Inflammation , 2014, Reproductive Sciences.
[20] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[21] L. Ortiz,et al. LPS-treated macrophage cytokines repress surfactant protein-B in lung epithelial cells. , 2013, American journal of respiratory cell and molecular biology.
[22] M. Rüdiger,et al. Pulmonary Surfactant Preserves Viability of Alveolar Type II Cells Exposed to Polymyxin B In Vitro , 2013, PloS one.
[23] H. Trübel,et al. Lipopolysaccharide-induced acute lung injury in rats: comparative assessment of intratracheal instillation and aerosol inhalation. , 2013, Toxicology.
[24] Dave Singh,et al. Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects. , 2012, British journal of clinical pharmacology.
[25] J. Li,et al. Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. , 2012, The Journal of antimicrobial chemotherapy.
[26] S. Sanyal,et al. Cycloxygenase Inhibition Enhances the Effects of Surfactant Therapy in Endotoxin-Induced Rat Model of ARDS , 2011, Inflammation.
[27] Ta-Liang Chen,et al. Lipopolysaccharide induces apoptotic insults to human alveolar epithelial A549 cells through reactive oxygen species-mediated activation of an intrinsic mitochondrion-dependent pathway , 2011, Archives of Toxicology.
[28] Sanford Weisberg,et al. An R Companion to Applied Regression , 2010 .
[29] Jie Fan,et al. Association of Toll-Like Receptor Signaling and Reactive Oxygen Species: A Potential Therapeutic Target for Posttrauma Acute Lung Injury , 2010, Mediators of inflammation.
[30] C. Bosquillon,et al. Drug transporters in the lung--do they play a role in the biopharmaceutics of inhaled drugs? , 2010, Journal of pharmaceutical sciences.
[31] R. Andersson,et al. Variation of lipopolysaccharide-induced acute lung injury in eight strains of mice , 2010, Respiratory Physiology & Neurobiology.
[32] E. Herting,et al. Prophylactic Intratracheal Polymyxin B/Surfactant Prevents Bacterial Growth in Neonatal Escherichia coli Pneumonia of Rabbits , 2010, Pediatric Research.
[33] T. Espevik,et al. Meconium-induced release of cytokines is mediated by the TRL4/MD-2 complex in a CD14-dependent manner. , 2010, Molecular immunology.
[34] Susan E Wert,et al. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. , 2010, Annual review of medicine.
[35] E. Ozyilmaz,et al. Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? , 2010, Intensive Care Medicine.
[36] Z. Sever-Chroneos,et al. Pulmonary Surfactant: An Immunological Perspective , 2009, Cellular Physiology and Biochemistry.
[37] R. Niven,et al. KL4‐surfactant prevents hyperoxic and LPS‐induced lung injury in mice , 2006, Pediatric pulmonology.
[38] C. Booy,et al. Ropivacaine decreases inflammation in experimental endotoxin-induced lung injury. , 2006 .
[39] J. Johansson,et al. Polymyxin B/Pulmonary Surfactant Mixtures Have Increased Resistance to Inactivation by Meconium and Reduce Growth of Gram-Negative Bacteria In Vitro , 2006, Pediatric Research.
[40] M. Falagas,et al. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies , 2006, Critical care.
[41] J. Johansson,et al. Biophysical and Physiological Properties of Porcine Surfactant Enriched with Polymyxin B , 2005, Neonatology.
[42] Xiangdong Wang,et al. Lung Inflammatory Responses and Hyperinflation Induced by an Intratracheal Exposure to Lipopolysaccharide in Rats , 2004, Lung.
[43] J. Johansson,et al. Interaction of Pulmonary Surfactant Protein C with CD14 and Lipopolysaccharide , 2003, Infection and Immunity.
[44] S. Holland,et al. In vivo lipid‐derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDS , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[45] J. Johansson,et al. Structural Basis for Interactions between Lung Surfactant Protein C and Bacterial Lipopolysaccharide* , 2002, The Journal of Biological Chemistry.
[46] V. Glumoff,et al. Regulation of surfactant proteins by LPS and proinflammatory cytokines in fetal and newborn lung. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[47] C. Ruppert,et al. Surfactant alteration and replacement in acute respiratory distress syndrome , 2001, Respiratory research.
[48] J. Schulte‐Mönting,et al. Alveolar Recruitment Promotes Homogeneous Surfactant Distribution in a Piglet Model of Lung Injury , 2001, Pediatric Research.
[49] E. Ingenito,et al. Decreased surfactant protein-B expression and surfactant dysfunction in a murine model of acute lung injury. , 2001, American journal of respiratory cell and molecular biology.
[50] B. Persson,et al. Pulmonary surfactant protein B: a structural model and a functional analogue. , 2000, Biochimica et biophysica acta.
[51] M. R. Brown,et al. Antimicrobial properties of liposomal polymyxin B. , 1999, The Journal of antimicrobial chemotherapy.
[52] H. Haagsman,et al. Efficacy of Curosurf in a rat model of acute respiratory distress syndrome. , 1998, The European respiratory journal.
[53] K. Brogden,et al. Complexing of bacterial lipopolysaccharide with lung surfactant , 1986, Infection and immunity.
[54] L. Greenfield,et al. Effects of endotoxin on pulmonary capillary permeability and surfactant. , 1968, Surgical forum.